Acceptability of dementia screening in primary care patients

International Journal of Geriatric Psychiatry

Volumn 26, Issue 4, 2011, Pages 373-379

  Holsinger, Tracey ^a   Boustani, Malaz ^a   Abbot, David ^a   Williams, John W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attitudes; Dementia; Harms; Screening

Indexed keywords

AGED; ARTICLE; DEMENTIA; FEMALE; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; PATIENT ATTITUDE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RISK FACTOR;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES;

EID: 79952753196     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2536     Document Type: Article

References (30)

1. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M. 2000. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev 4: CD001191.
2. Birks JS, Melzer D. 2000. Donepezil for mild and moderate Alzheimer's disease. Cochrane Database Syst Rev CD001190.
3. Bland JM, Altman DG. 1997. Cronbach's alpha. BMJ 314: 572. (Pubitemid 27089377)
4. Boustani M, Perkins AJ, Fox C, et al. 2006. Who refuses the diagnostic assessment for dementia in primary care? Int J Geriatr Psychiatry 21: 556-563.
5. Boustani M, Perkins AJ, Monahan P, et al. 2008. Measuring primary care patients' attitudes about dementia screening. Int J Geriatr Psychiatry 23: 812-820.
6. Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. 2003a. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 138: 927-937.
7. Boustani M, Watson L, Fultz B, Perkins AJ, Druckenbrod R. 2003b. Acceptance of dementia screening in continuous care retirement communities: a mailed survey. Int J Geriatr Psychiatry 18: 780-786. (Pubitemid 37150481)
8. Bynum JP, Rabins PV, Weller W, et al. 2004. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc 52: 187-194. (Pubitemid 38233479)
9. Callahan CM, Hendrie HC, Tierney WM. 1995. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 122: 422-429.
10. Canadian study of health and aging. 1994. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 150: 899-913.
11. Christensen DD. 2007. Alzheimer's disease: progress in the development of antiamyloid disease-modifying therapies. CNS Spectr 12: 113-116, 119-123.
12. Doody RS, Stevens JC, Beck C, et al. 2001. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56: 1154-1166.
13. Ernst RL, Hay JW. 1994. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 84: 1261-1264. (Pubitemid 24250694)
14. Green RC, Roberts JS, Cupples LA, et al. 2009. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 361: 245-254.
15. Hosmer DW, Lemeshow S. 2000. Applied Logistic Regression. Wiley: New York.
16. Justiss MD, Boustani M, Fox C, et al. 2008. Patients' attitudes of dementia screening across the Atlantic. Int J Geriatr Psychiatry 24: 632-637.
17. Kelly KM, Dickinson SL, Degraffinreid CR, Tatum CM, Paskett ED. 2007. Colorectal cancer screening in 3 racial groups. Am J Health Behav 31: 502-513.
18. Lobo A, Launer LJ, Fratiglioni L, et al. 2000. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54: S4-S9. (Pubitemid 30390598)
19. Malouf R, Birks J. 2004. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev 1: CD004395.
20. Martin BC, Ricci JF, Kotzan JA, Lang K, Menzin J. 2000. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord 14: 151-159.
21. Mcshane R, Sastre Areosa A, Minakaran N. 2006. Memantine for dementia. Cochrane Database Syst Rev 2: CD003154.
22. Olafsdottir M, Skoog I, Marcusson J. 2000. Detection of dementia in primary care: the Linkoping study. Dement Geriatr Cogn Disord 11: 223-229. (Pubitemid 30416028)
23. Olin J, Schneider L. 2002. Galantamine for Alzheimer's disease. Cochrane Database Syst Rev 3: CD001747.
24. Plassman BL, Langa KM, Fisher GG, et al. 2007. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29: 125-132. (Pubitemid 350191430)
25. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. (ed.). 1991. Clinical Epidemiology: A Basic Science for Clinical Medicine. Little, Brown and Company: Boston/Toronto/London.
26. Seeff LC, Nadel MR, Klabunde CN, et al. 2004. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 100: 2093-2103. (Pubitemid 38580326)
27. Selkoe DJ. 2004. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 140: 627-638.
28. Teri L, Gibbons LE, Mccurry SM, et al. 2003. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 290: 2015-2022. (Pubitemid 37430584)
29. Valcour VG, Masaki KH, Curb JD, Blanchette PL. 2000. The detection of dementia in the primary care setting. Arch Intern Med 160: 2964-2968. (Pubitemid 32009054)
30. Weiner M, Powe NR, Weller WE, Shaffer TJ, Anderson GF. 1998. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc 46: 762-770. (Pubitemid 128722276)